Trial NCT03064854

View at ClinicalTrials.gov 
Org. Study IDs: CPDR001C2101
Secondary IDs: 2016-002815-17

Last trial update was posted on 2022-08-15

MeSH Interventions

Carboplatin Gemcitabine Paclitaxel Pemetrexed Spartalizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

Recruitment halted prematurely due to competitive landscape for lung cancer therapies

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID